Are things looking up for Valeant Pharmaceuticals International (VRX)? The outlook for the drug maker’s debt seems to be improving, at least according

CeuntryLink shares have dropped 5{c97747fc6669eeabccae72a612b98144a9761deaf7841779826c1625931c3d62} after earnings bad enough to call its dividend

Some energy partnerships could boost returns after a tough year. Mizuho sees upside for two divergent MLPs.

CenturyLink's first earnings report after closing its Level 3 Communications acquisition was a disappointment.

A year after new regulations governing money-market mutual funds went into effect, investors are returning to so-called prime funds, according to

Moody’s has upgraded India’s sovereign debt for the first time in more than a decade. Investors should question the timing.